Status:
COMPLETED
Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
Lead Sponsor:
Ankara Etlik City Hospital
Conditions:
Postpartum Hemorrhage
Cesarean Section Complications
Eligibility:
FEMALE
18-45 years
Brief Summary
Postpartum hemorrhage (PPH) is an obstetric emergency, with an estimated incidence ranging from 2.8% to 7.9%. Recent studies indicate an increasing trend in the frequency of PPH.Although it is more co...
Detailed Description
The study included emergency or elective cases scheduled for cesarean delivery at the Obstetrics and Gynecology Clinic, Maternity Ward of Etlik City Hospital, between December 2023 and December 2024. ...
Eligibility Criteria
Inclusion
- Patients aged 18-45 years
- gestational age between 37 and 41 weeks
- Perfomed ceserean section for delivery
Exclusion
- did not provide informed consent,
- with comorbidities (such as heart, liver, or lung diseases),
- high-risk pregnancy (e.g., intrauterine growth restriction, cholestasis, preeclampsia, eclampsia, multiple pregnancies)
- known allergies to tranexamic acid or misoprostol
- known coagulation disorders
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06970483
Start Date
December 1 2023
End Date
December 1 2024
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etlik City Hospital
Ankara, Turkey (Türkiye)